Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemias (CMML) are often associated to auto-immune or inflammatory manifestations (AIMs). Efficacy of azacytidine (AZA) in the management of these AIMs is debated. We conducted a case-control study towards MDS/CMML treated by AZA in Nice University Hospital between 2005 and 2019 to...
-
September 15, 2020 (v1)PublicationUploaded on: December 4, 2022
-
March 22, 2022 (v1)Journal article
Background The French Riviera has been declared free of Lyme Borreliosis (LB) for years. Many patients are referred for presumed LB, sometimes with atypical clinical signs and/or doubtful serology, calling the diagnosis into question. Methods Patients were assessed for LB diagnosis, depending on clinical presentation, laboratory findings, and...
Uploaded on: December 3, 2022